Ian C. Read was the CEO of Pfizer Inc. from 2010 to 2018, where he played a huge role in expanding the company's global business. Under his leadership, Pfizer focused on linking executive pay to company performance, making sure that...
Ian C. Read was the CEO of Pfizer Inc. from 2010 to 2018, where he played a huge role in expanding the company's global business. Under his leadership, Pfizer focused on linking executive pay to company performance, making sure that top management profits only when the company does well. By 2019, Read owned 1.6 million shares of Pfizer worth around $46.5 million, a move that showed his commitment to the company and its shareholders. His compensation reflected this drive, with a total earnings package that surpassed $10 million in 2018, mostly from bonuses tied to Pfizer's revenue and profits. Before becoming CEO, Read joined Pfizer in 1978 and climbed the ranks, including serving as President of Worldwide Pharmaceutical Operations. After stepping down as CEO, he took on a consulting role to help with strategic projects, showing he was still invested in Pfizer's future. Overall, Read’s leadership style demonstrated a focus on results and accountability, contributing to Pfizer's success in the pharmaceutical industry.